Prescription Medicine Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: P7E17C71F2E7EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Prescription Medicine in Global, including the following market information:

Global Prescription Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Prescription Medicine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prescription Medicine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Prescription Medicine Market Segment Percentages, By Type, 2020 (%)

• Original Brand Drug
• Generic Drug

China Prescription Medicine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Prescription Medicine Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Online
• Others

Global Prescription Medicine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Prescription Medicine Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Prescription Medicine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Prescription Medicine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• Roche
• Novartis
• Johnson & Johnson
• Merck & Co.
• Sanofi
• AbbVie
• GlaxoSmithKline
• Amgen
• Gilead Science
• Bristol-Myers Squibb
• AstraZeneca
• Eli Lilly
• Bayer
• Novo Nordisk
• Takeda
• Boehringer-Ingelheim
• Allergan
• Teva Pharmaceutical Industries
• Mylan
• Astellas Pharma
• Biogen
• CSL
• Daiichi Sankyo
• Otsuka Holdings
• UCB
• LES LABORATOIRES SERVIER
• Bausch Health Companies
• Eisai
• Abbott Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prescription Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prescription Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PRESCRIPTION MEDICINE OVERALL MARKET SIZE

2.1 Global Prescription Medicine Market Size: 2021 VS 2027
2.2 Global Prescription Medicine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Prescription Medicine Players in Global Market
3.2 Top Global Prescription Medicine Companies Ranked by Revenue
3.3 Global Prescription Medicine Revenue by Companies
3.4 Top 3 and Top 5 Prescription Medicine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Prescription Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prescription Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Prescription Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Prescription Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Prescription Medicine Market Size Markets, 2021 & 2027
  4.1.2 Original Brand Drug
  4.1.3 Generic Drug
4.2 By Type - Global Prescription Medicine Revenue & Forecasts
  4.2.1 By Type - Global Prescription Medicine Revenue, 2016-2021
  4.2.2 By Type - Global Prescription Medicine Revenue, 2022-2027
  4.2.3 By Type - Global Prescription Medicine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prescription Medicine Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Online
  5.1.5 Others
5.2 By Application - Global Prescription Medicine Revenue & Forecasts
  5.2.1 By Application - Global Prescription Medicine Revenue, 2016-2021
  5.2.2 By Application - Global Prescription Medicine Revenue, 2022-2027
  5.2.3 By Application - Global Prescription Medicine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Prescription Medicine Market Size, 2021 & 2027
6.2 By Region - Global Prescription Medicine Revenue & Forecasts
  6.2.1 By Region - Global Prescription Medicine Revenue, 2016-2021
  6.2.2 By Region - Global Prescription Medicine Revenue, 2022-2027
  6.2.3 By Region - Global Prescription Medicine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Prescription Medicine Revenue, 2016-2027
  6.3.2 US Prescription Medicine Market Size, 2016-2027
  6.3.3 Canada Prescription Medicine Market Size, 2016-2027
  6.3.4 Mexico Prescription Medicine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Prescription Medicine Revenue, 2016-2027
  6.4.2 Germany Prescription Medicine Market Size, 2016-2027
  6.4.3 France Prescription Medicine Market Size, 2016-2027
  6.4.4 U.K. Prescription Medicine Market Size, 2016-2027
  6.4.5 Italy Prescription Medicine Market Size, 2016-2027
  6.4.6 Russia Prescription Medicine Market Size, 2016-2027
  6.4.7 Nordic Countries Prescription Medicine Market Size, 2016-2027
  6.4.8 Benelux Prescription Medicine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Prescription Medicine Revenue, 2016-2027
  6.5.2 China Prescription Medicine Market Size, 2016-2027
  6.5.3 Japan Prescription Medicine Market Size, 2016-2027
  6.5.4 South Korea Prescription Medicine Market Size, 2016-2027
  6.5.5 Southeast Asia Prescription Medicine Market Size, 2016-2027
  6.5.6 India Prescription Medicine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Prescription Medicine Revenue, 2016-2027
  6.6.2 Brazil Prescription Medicine Market Size, 2016-2027
  6.6.3 Argentina Prescription Medicine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Prescription Medicine Revenue, 2016-2027
  6.7.2 Turkey Prescription Medicine Market Size, 2016-2027
  6.7.3 Israel Prescription Medicine Market Size, 2016-2027
  6.7.4 Saudi Arabia Prescription Medicine Market Size, 2016-2027
  6.7.5 UAE Prescription Medicine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Prescription Medicine Major Product Offerings
  7.1.4 Pfizer Prescription Medicine Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Prescription Medicine Major Product Offerings
  7.2.4 Roche Prescription Medicine Revenue in Global (2016-2021)
  7.2.5 Roche Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Prescription Medicine Major Product Offerings
  7.3.4 Novartis Prescription Medicine Revenue in Global (2016-2021)
  7.3.5 Novartis Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Prescription Medicine Major Product Offerings
  7.4.4 Johnson & Johnson Prescription Medicine Revenue in Global (2016-2021)
  7.4.5 Johnson & Johnson Key News
7.5 Merck & Co.
  7.5.1 Merck & Co. Corporate Summary
  7.5.2 Merck & Co. Business Overview
  7.5.3 Merck & Co. Prescription Medicine Major Product Offerings
  7.5.4 Merck & Co. Prescription Medicine Revenue in Global (2016-2021)
  7.5.5 Merck & Co. Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Prescription Medicine Major Product Offerings
  7.6.4 Sanofi Prescription Medicine Revenue in Global (2016-2021)
  7.6.5 Sanofi Key News
7.7 AbbVie
  7.7.1 AbbVie Corporate Summary
  7.7.2 AbbVie Business Overview
  7.7.3 AbbVie Prescription Medicine Major Product Offerings
  7.4.4 AbbVie Prescription Medicine Revenue in Global (2016-2021)
  7.7.5 AbbVie Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Prescription Medicine Major Product Offerings
  7.8.4 GlaxoSmithKline Prescription Medicine Revenue in Global (2016-2021)
  7.8.5 GlaxoSmithKline Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Prescription Medicine Major Product Offerings
  7.9.4 Amgen Prescription Medicine Revenue in Global (2016-2021)
  7.9.5 Amgen Key News
7.10 Gilead Science
  7.10.1 Gilead Science Corporate Summary
  7.10.2 Gilead Science Business Overview
  7.10.3 Gilead Science Prescription Medicine Major Product Offerings
  7.10.4 Gilead Science Prescription Medicine Revenue in Global (2016-2021)
  7.10.5 Gilead Science Key News
7.11 Bristol-Myers Squibb
  7.11.1 Bristol-Myers Squibb Corporate Summary
  7.11.2 Bristol-Myers Squibb Business Overview
  7.11.3 Bristol-Myers Squibb Prescription Medicine Major Product Offerings
  7.11.4 Bristol-Myers Squibb Prescription Medicine Revenue in Global (2016-2021)
  7.11.5 Bristol-Myers Squibb Key News
7.12 AstraZeneca
  7.12.1 AstraZeneca Corporate Summary
  7.12.2 AstraZeneca Business Overview
  7.12.3 AstraZeneca Prescription Medicine Major Product Offerings
  7.12.4 AstraZeneca Prescription Medicine Revenue in Global (2016-2021)
  7.12.5 AstraZeneca Key News
7.13 Eli Lilly
  7.13.1 Eli Lilly Corporate Summary
  7.13.2 Eli Lilly Business Overview
  7.13.3 Eli Lilly Prescription Medicine Major Product Offerings
  7.13.4 Eli Lilly Prescription Medicine Revenue in Global (2016-2021)
  7.13.5 Eli Lilly Key News
7.14 Bayer
  7.14.1 Bayer Corporate Summary
  7.14.2 Bayer Business Overview
  7.14.3 Bayer Prescription Medicine Major Product Offerings
  7.14.4 Bayer Prescription Medicine Revenue in Global (2016-2021)
  7.14.5 Bayer Key News
7.15 Novo Nordisk
  7.15.1 Novo Nordisk Corporate Summary
  7.15.2 Novo Nordisk Business Overview
  7.15.3 Novo Nordisk Prescription Medicine Major Product Offerings
  7.15.4 Novo Nordisk Prescription Medicine Revenue in Global (2016-2021)
  7.15.5 Novo Nordisk Key News
7.16 Takeda
  7.16.1 Takeda Corporate Summary
  7.16.2 Takeda Business Overview
  7.16.3 Takeda Prescription Medicine Major Product Offerings
  7.16.4 Takeda Prescription Medicine Revenue in Global (2016-2021)
  7.16.5 Takeda Key News
7.17 Boehringer-Ingelheim
  7.17.1 Boehringer-Ingelheim Corporate Summary
  7.17.2 Boehringer-Ingelheim Business Overview
  7.17.3 Boehringer-Ingelheim Prescription Medicine Major Product Offerings
  7.17.4 Boehringer-Ingelheim Prescription Medicine Revenue in Global (2016-2021)
  7.17.5 Boehringer-Ingelheim Key News
7.18 Allergan
  7.18.1 Allergan Corporate Summary
  7.18.2 Allergan Business Overview
  7.18.3 Allergan Prescription Medicine Major Product Offerings
  7.18.4 Allergan Prescription Medicine Revenue in Global (2016-2021)
  7.18.5 Allergan Key News
7.19 Teva Pharmaceutical Industries
  7.19.1 Teva Pharmaceutical Industries Corporate Summary
  7.19.2 Teva Pharmaceutical Industries Business Overview
  7.19.3 Teva Pharmaceutical Industries Prescription Medicine Major Product Offerings
  7.19.4 Teva Pharmaceutical Industries Prescription Medicine Revenue in Global (2016-2021)
  7.19.5 Teva Pharmaceutical Industries Key News
7.20 Mylan
  7.20.1 Mylan Corporate Summary
  7.20.2 Mylan Business Overview
  7.20.3 Mylan Prescription Medicine Major Product Offerings
  7.20.4 Mylan Prescription Medicine Revenue in Global (2016-2021)
  7.20.5 Mylan Key News
7.21 Astellas Pharma
  7.21.1 Astellas Pharma Corporate Summary
  7.21.2 Astellas Pharma Business Overview
  7.21.3 Astellas Pharma Prescription Medicine Major Product Offerings
  7.21.4 Astellas Pharma Prescription Medicine Revenue in Global (2016-2021)
  7.21.5 Astellas Pharma Key News
7.22 Biogen
  7.22.1 Biogen Corporate Summary
  7.22.2 Biogen Business Overview
  7.22.3 Biogen Prescription Medicine Major Product Offerings
  7.22.4 Biogen Prescription Medicine Revenue in Global (2016-2021)
  7.22.5 Biogen Key News
7.23 CSL
  7.23.1 CSL Corporate Summary
  7.23.2 CSL Business Overview
  7.23.3 CSL Prescription Medicine Major Product Offerings
  7.23.4 CSL Prescription Medicine Revenue in Global (2016-2021)
  7.23.5 CSL Key News
7.24 Daiichi Sankyo
  7.24.1 Daiichi Sankyo Corporate Summary
  7.24.2 Daiichi Sankyo Business Overview
  7.24.3 Daiichi Sankyo Prescription Medicine Major Product Offerings
  7.24.4 Daiichi Sankyo Prescription Medicine Revenue in Global (2016-2021)
  7.24.5 Daiichi Sankyo Key News
7.25 Otsuka Holdings
  7.25.1 Otsuka Holdings Corporate Summary
  7.25.2 Otsuka Holdings Business Overview
  7.25.3 Otsuka Holdings Prescription Medicine Major Product Offerings
  7.25.4 Otsuka Holdings Prescription Medicine Revenue in Global (2016-2021)
  7.25.5 Otsuka Holdings Key News
7.26 UCB
  7.26.1 UCB Corporate Summary
  7.26.2 UCB Business Overview
  7.26.3 UCB Prescription Medicine Major Product Offerings
  7.26.4 UCB Prescription Medicine Revenue in Global (2016-2021)
  7.26.5 UCB Key News
7.27 LES LABORATOIRES SERVIER
  7.27.1 LES LABORATOIRES SERVIER Corporate Summary
  7.27.2 LES LABORATOIRES SERVIER Business Overview
  7.27.3 LES LABORATOIRES SERVIER Prescription Medicine Major Product Offerings
  7.27.4 LES LABORATOIRES SERVIER Prescription Medicine Revenue in Global (2016-2021)
  7.27.5 LES LABORATOIRES SERVIER Key News
7.28 Bausch Health Companies
  7.28.1 Bausch Health Companies Corporate Summary
  7.28.2 Bausch Health Companies Business Overview
  7.28.3 Bausch Health Companies Prescription Medicine Major Product Offerings
  7.28.4 Bausch Health Companies Prescription Medicine Revenue in Global (2016-2021)
  7.28.5 Bausch Health Companies Key News
7.29 Eisai
  7.29.1 Eisai Corporate Summary
  7.29.2 Eisai Business Overview
  7.29.3 Eisai Prescription Medicine Major Product Offerings
  7.29.4 Eisai Prescription Medicine Revenue in Global (2016-2021)
  7.29.5 Eisai Key News
7.30 Abbott Laboratories
  7.30.1 Abbott Laboratories Corporate Summary
  7.30.2 Abbott Laboratories Business Overview
  7.30.3 Abbott Laboratories Prescription Medicine Major Product Offerings
  7.30.4 Abbott Laboratories Prescription Medicine Revenue in Global (2016-2021)
  7.30.5 Abbott Laboratories Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Prescription Medicine Market Opportunities & Trends in Global Market
Table 2. Prescription Medicine Market Drivers in Global Market
Table 3. Prescription Medicine Market Restraints in Global Market
Table 4. Key Players of Prescription Medicine in Global Market
Table 5. Top Prescription Medicine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Prescription Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Prescription Medicine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Prescription Medicine Product Type
Table 9. List of Global Tier 1 Prescription Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Prescription Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Prescription Medicine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Prescription Medicine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Prescription Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Prescription Medicine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Prescription Medicine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Prescription Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Prescription Medicine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Prescription Medicine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Prescription Medicine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Prescription Medicine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Prescription Medicine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Prescription Medicine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Prescription Medicine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Prescription Medicine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Prescription Medicine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Prescription Medicine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Prescription Medicine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Prescription Medicine Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Prescription Medicine Product Offerings
Table 32. Pfizer Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 33. Roche Corporate Summary
Table 34. Roche Prescription Medicine Product Offerings
Table 35. Roche Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 36. Novartis Corporate Summary
Table 37. Novartis Prescription Medicine Product Offerings
Table 38. Novartis Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Prescription Medicine Product Offerings
Table 41. Johnson & Johnson Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 42. Merck & Co. Corporate Summary
Table 43. Merck & Co. Prescription Medicine Product Offerings
Table 44. Merck & Co. Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Prescription Medicine Product Offerings
Table 47. Sanofi Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 48. AbbVie Corporate Summary
Table 49. AbbVie Prescription Medicine Product Offerings
Table 50. AbbVie Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Prescription Medicine Product Offerings
Table 53. GlaxoSmithKline Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 54. Amgen Corporate Summary
Table 55. Amgen Prescription Medicine Product Offerings
Table 56. Amgen Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 57. Gilead Science Corporate Summary
Table 58. Gilead Science Prescription Medicine Product Offerings
Table 59. Gilead Science Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 60. Bristol-Myers Squibb Corporate Summary
Table 61. Bristol-Myers Squibb Prescription Medicine Product Offerings
Table 62. Bristol-Myers Squibb Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Prescription Medicine Product Offerings
Table 65. AstraZeneca Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Prescription Medicine Product Offerings
Table 68. Eli Lilly Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 69. Bayer Corporate Summary
Table 70. Bayer Prescription Medicine Product Offerings
Table 71. Bayer Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 72. Novo Nordisk Corporate Summary
Table 73. Novo Nordisk Prescription Medicine Product Offerings
Table 74. Novo Nordisk Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 75. Takeda Corporate Summary
Table 76. Takeda Prescription Medicine Product Offerings
Table 77. Takeda Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 78. Boehringer-Ingelheim Corporate Summary
Table 79. Boehringer-Ingelheim Prescription Medicine Product Offerings
Table 80. Boehringer-Ingelheim Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 81. Allergan Corporate Summary
Table 82. Allergan Prescription Medicine Product Offerings
Table 83. Allergan Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 84. Teva Pharmaceutical Industries Corporate Summary
Table 85. Teva Pharmaceutical Industries Prescription Medicine Product Offerings
Table 86. Teva Pharmaceutical Industries Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 87. Mylan Corporate Summary
Table 88. Mylan Prescription Medicine Product Offerings
Table 89. Mylan Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 90. Astellas Pharma Corporate Summary
Table 91. Astellas Pharma Prescription Medicine Product Offerings
Table 92. Astellas Pharma Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 93. Biogen Corporate Summary
Table 94. Biogen Prescription Medicine Product Offerings
Table 95. Biogen Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 96. CSL Corporate Summary
Table 97. CSL Prescription Medicine Product Offerings
Table 98. CSL Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 99. Daiichi Sankyo Corporate Summary
Table 100. Daiichi Sankyo Prescription Medicine Product Offerings
Table 101. Daiichi Sankyo Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 102. Otsuka Holdings Corporate Summary
Table 103. Otsuka Holdings Prescription Medicine Product Offerings
Table 104. Otsuka Holdings Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 105. UCB Corporate Summary
Table 106. UCB Prescription Medicine Product Offerings
Table 107. UCB Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 108. LES LABORATOIRES SERVIER Corporate Summary
Table 109. LES LABORATOIRES SERVIER Prescription Medicine Product Offerings
Table 110. LES LABORATOIRES SERVIER Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 111. Bausch Health Companies Corporate Summary
Table 112. Bausch Health Companies Prescription Medicine Product Offerings
Table 113. Bausch Health Companies Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 114. Eisai Corporate Summary
Table 115. Eisai Prescription Medicine Product Offerings
Table 116. Eisai Prescription Medicine Revenue (US$, Mn), (2016-2021)
Table 117. Abbott Laboratories Corporate Summary
Table 118. Abbott Laboratories Prescription Medicine Product Offerings
Table 119. Abbott Laboratories Prescription Medicine Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Prescription Medicine Segment by Type
Figure 2. Prescription Medicine Segment by Application
Figure 3. Global Prescription Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Prescription Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Prescription Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prescription Medicine Revenue in 2020
Figure 8. By Type - Global Prescription Medicine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Prescription Medicine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Prescription Medicine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Prescription Medicine Revenue Market Share, 2016-2027
Figure 12. US Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Prescription Medicine Revenue Market Share, 2016-2027
Figure 16. Germany Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 17. France Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Prescription Medicine Revenue Market Share, 2016-2027
Figure 24. China Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 28. India Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Prescription Medicine Revenue Market Share, 2016-2027
Figure 30. Brazil Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Prescription Medicine Revenue Market Share, 2016-2027
Figure 33. Turkey Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Prescription Medicine Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Roche Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johnson & Johnson Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Merck & Co. Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sanofi Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. AbbVie Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. GlaxoSmithKline Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Amgen Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Gilead Science Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Bristol-Myers Squibb Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. AstraZeneca Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Eli Lilly Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bayer Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Novo Nordisk Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Takeda Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Boehringer-Ingelheim Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Allergan Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Teva Pharmaceutical Industries Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Mylan Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Astellas Pharma Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Biogen Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. CSL Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Daiichi Sankyo Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Otsuka Holdings Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. UCB Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. LES LABORATOIRES SERVIER Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. Bausch Health Companies Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 65. Eisai Prescription Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)